A Pre-Commercial Procurement Project for improving cancer patients' benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmocogenetics testing and e-medication in proper presentation to medical doctors for supporting therapy decision making at bedside.

This 60 month H2020 project started in January 2020. 
The maximum Grant Agreement amount is €10.998.128,16  

Cofunded by the European Union under Grant Agreement No. 874719